Diversity statements aren't enough -- Karamo's helping thousands of businesses to create more inclusive workplaces
Karamo Brown launches free Diversity, Equity and Inclusion (DEI) training with Aussie microlearni...
ViewSonic's Innovative All-in-One LED Display Captivated People During an Exhibition at German Architekturmuseum Der TUM
BREA, Calif., Nov. 18, 2021 /PRNewswire/ -- ViewSonic Corp.
Fragrance and flavor industries show positive results in first sector-wide Sustainability Report
SINGAPORE, June 29, 2021 /PRNewswire/ -- The first collective Sustainability Report by the fragranc...
Avon Foundation for Women announces new funding for Vital Voices, marking a ten-year partnership aimed at ending gender-based violence
LONDON, July 11, 2019 /PRNewswire/ -- Avon and the Avon Foundation for Women today announced a new$...
ASCO 2022 | Ascentage Pharma Releases for the First Time Results of its FAK/ALK/ROS1 inhibitor APG-2449 Demonstrating Safety and Efficacy in Patients with Advanced NSCLC
SUZHOU, China, and ROCKVILLE, MD, June 7, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global...
CGTN: Tech, politics and ambition: How Huawei's Meng Wanzhou stepped into a perfect storm between China and U.S.
Meng Wanzhou's release reveals Washington's attempt to prevent its stiff competition withBeijing fr...
Merck Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine Manufacturing
- Recently developed manufacturing platform allows large-scale manufacturing - Joint team reduced p...
Merck Announces Update on the INTR@PID Clinical Program Including Lung 037 Study
DARMSTADT, Germany, Jan. 20, 2021 /PRNewswire/ -- Not intended for US-, Canada- or UK-based media ...
RedHill Biopharma's Phase 2/3 COVID-19 Study of Opaganib Passes Fourth DSMB Review with Unanimous Recommendation to Continue
Independent Data Safety Monitoring Board unanimously recommends continuation of the global Phase 2/...
51job, Inc. Enters into an Amended Merger Agreement for Going-Private Transaction
SHANGHAI, March 1, 2022 /PRNewswire/ -- 51job, Inc. (Nasdaq: JOBS) ("51job" or the "Company"), a le...
CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
First non-immunosuppressive therapy for the treatment of IgA Nephropathy (IgAN) approved inEurope ...
Transcenta Announces Encouraging Phase I Clinical Data of TST002 (Blosozumab) in Chinese Patients with Reduced Bone Mineral Density
SUZHOU, China, May 17, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628)...
Accenture Named a Leader in New IDC MarketScape Report for Firms Providing Digital Transformation Services to the Asia-Pacific Utilities Industry
BEIJING, Sept. 7, 2022 /PRNewswire/ -- Accenture (NYSE: ACN) has been positioned as a leader in the...
RedHill Biopharma Announces Positive DSMB Futility Review for Phase 2/3 COVID-19 Study of Opaganib
TEL AVIV, Israel and RALEIGH, N.C., Jan. 29, 2021 /PRNewswire/ -- RedHill
Biopharma Ltd.
Brii Biosciences Provides Corporate Updates and Reports 2023 Interim Results
First patient dosed in a PEG-IFN-α controlled BRII-835 + PEG-IFN-α combination Phase 2 study for HB...
GLOBAL SENSATION, FLEURS DE VILLES, RETURNS TO THE ROYAL BOTANIC GARDEN SYDNEY FOR A CELEBRATION OF JOY AND INCLUSIVITY WITH THEIR 'PRIDE' FLORAL SHOW
From 17 - 26 February, experience Fleurs de Villes PRIDE at the Royal Botanic Garden Sydney, a 10-d...
Everest Medicines Announces that Licensing Partner Venatorx Pharmaceuticals Reports Positive Results from Pivotal Phase 3 Cefepime-Taniborbactam Trial
SHANGHAI, March 10, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announced today that its ...
Artmarket.com: 2024 Q1 revenue growth… AI with the Intuitive Artmarket® in Artprice databases… New high value-added services and subscriptions
PARIS, May 15, 2024 /PRNewswire/ -- As Artificial Intelligence sweeps across the planet like a tsun...
Zai Lab Announces First Quarter 2022 Financial Results and Corporate Updates
Company to Host Conference Call and Webcast on May 11, 2022, at 8:00 a.m. ET SHANGHAI and SAN FRANC...
INOVIO Reports Positive Interim Phase 2 VGX-3100 Results In Patients with HPV-associated Anal Dysplasia
- VGX-3100 DNA medicine cleared high-risk HPV 16/18-associated precancerous lesions in 50% of patie...